How to buy Solta Medical Corporation (SLTA) stock

Solta Medical Corporation is expected to go public soon. Here's what we know about the IPO — and how to buy Solta Medical Corporation stock when it's available.

What we know about the Solta Medical Corporation IPO

Solta Medical Corporation filed a registration form with the US Securities and Exchange Commission (SEC) to go public on the Nasdaq Global Select Market under the ticker symbol SLTA. Not yet an official IPO, this is one of the first steps of taking a private company public.

The exact IPO date has not been announced. There's no news yet about how much the stock will cost when it goes public. We'll update this page with more information as it becomes available.

How to buy Solta Medical Corporation stock when it starts trading

Once Solta Medical Corporation goes public, you'll need a brokerage account to invest. Consider opening a brokerage account today so you're ready as soon as the stock hits the market.

Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – SLTA – and research it before deciding if it's a good investment for you.
Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.

Finder's picks for buying Solta Medical Corporation stock when it goes public

Go to site

Commission-free stock trading

No-cost financial planning and automated investing
$0 commission on stocks, ETFs and options
Get up to $1,000 in stock when you fund a new account within 30 days

Go to site

$200 in US stocks

Trade options, futures, options on futures, stocks, ETFs
$0 commission to close options
Get $100-$5,000 when you open an account with $5,000 to $1,000,000+

Go to site

Easy access to diverse assets

Trade stocks, bonds, options, ETFs, crypto, Treasurys, collectibles, royalties
Earn 5.1% APY on your cash
Earn a $0.18 rebate on options, with no commissions and no per-contract fees

How do similar companies perform?

It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy Solta Medical Corporation stock.

See how the following stocks are performing, and view details like market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield.

Company summary
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
Historical performance
Stock information
- Market capitalization: $19301984256
- PEG ratio: 4.296
- Dividend yield: N/A%
Get more detailed information and learn how to buy ILMN.US stock
Company summary
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Historical performance
Stock information
- Market capitalization: $189499015168
- P/E ratio: 33.3976
- PEG ratio: 5.9854
- Dividend yield: 0.0201%
Get more detailed information and learn how to buy ABT.US stock
Company summary
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Historical performance
Stock information
- Market capitalization: $51774664704
- P/E ratio: 103.3077
- PEG ratio: 2.5317
- Dividend yield: N/A%
Get more detailed information and learn how to buy DXCM.US stock

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

1 - 6 of 6

Name	Ratings	Available asset types	Minimum deposit	Stock trade fee	Cash sweep APY	Signup bonus
SoFi Invest® Finder Score: 4.1 / 5: ★★★★★ SoFi Invest® Finder Score: 4.1 / 5: ★★★★★	★★★★★	Stocks, Mutual funds, ETFs, Alternatives	$0	$0		Get up to $1,000 in stock when you fund a new Active Invest account	Go to site More Info		loading Fetching your data...
Tastytrade Finder Score: 4.6 / 5: ★★★★★ Tastytrade Finder Score: 4.6 / 5: ★★★★★	★★★★★	Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills	$0	$0	N/A	Get $100-$5,000 when you open and fund an account with $5,000 to $1,000,000+	Highly commended for Best Derivatives Trading Platform award.	Go to site More Info		loading Fetching your data...
Public.com Finder Score: 4.1 / 5: ★★★★★ Public.com Finder Score: 4.1 / 5: ★★★★★	★★★★★	Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles	$0	$0	5.1%	N/A	2.5% fee applies to all alternative asset transactions.	Go to site More Info		loading Fetching your data...
Robinhood Gold Finder Score: 4.3 / 5: ★★★★★ Robinhood Gold Finder Score: 4.3 / 5: ★★★★★	★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	5%	Get a free stock when you successfully sign up and link your bank account.	Try Robinhood Gold for 30 days risk-free upon signup and earn a 5% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period.	Go to site More Info		loading Fetching your data...
Moomoo Finder Score: 4.7 / 5: ★★★★★ Moomoo Finder Score: 4.7 / 5: ★★★★★ Exclusive	★★★★★	Stocks, Options, ETFs	$0	$0	5.10%	Choose a 1.5% match or 7 free fractional shares when you open a new account and meet funding requirements	No commission stock and ETF trading, with a chance to get a 1.5% cash reward match or 7 free fractional shares.	Go to site More Info		loading Fetching your data...
Robinhood Finder Score: 4.3 / 5: ★★★★★ Robinhood Finder Score: 4.3 / 5: ★★★★★	★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	1.5%, or 5% with Robinhood Gold	Get a free stock when you successfully sign up and link your bank account.	Try Robinhood Gold for 30 days risk-free upon signup and earn a 5% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period.	Go to site More Info		loading Fetching your data...

loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

More on investing

How to buy FAANG stocks

Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.

Read more…

How to buy soccer stocks

A simple guide to buying stocks in your favorite European soccer team.

Read more…

Inflation stocks

Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.

Read more…

Thank you for your feedback!

How to buy ServiceTitan stock when it goes public How to buy SOBR Safe (SOBR) stock when it goes public

More guides on Finder

How to buy Savage X Fenty stock when it goes public
Everything we know about the Savage X Fenty IPO, plus information on how to buy in.
How to buy DeLorean Motor Company stock when it goes public
Everything we know about the DeLorean Motor Company IPO, plus information on how to buy in.
How to buy Griid (GRDI) stock when it goes public
Everything we know about the Griid IPO, plus information on how to buy in.
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
How to buy Kraig Biocraft Laboratories Inc (KBLB) stock when it goes public
Everything we know about the Kraig Biocraft Laboratories IPO, plus information on how to buy in.
Chime IPO: how to buy Chime stock when it goes public
Everything we know about the Chime IPO, plus information on how to buy in.
How to buy Instacart stock (CART)
Everything we know about the Instacart IPO, plus information on how to buy in.
How to buy Databricks stock when it goes public
Everything we know about the Databricks IPO, plus information on how to buy in.
TikTok IPO: How to buy TikTok stock when it goes public
Everything we know about the TikTok IPO, plus information on how to buy in.
How to buy Grail (GRAL) stock when it goes public
Everything we know about the Grail IPO, plus information on how to buy in.

Ask a Question

Click here to cancel reply.

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

How to buy Solta Medical Corporation (SLTA) stock when it goes public

Here's everything we know so far about the Solta Medical Corporation IPO.

What we know about the Solta Medical Corporation IPO

How to buy Solta Medical Corporation stock when it starts trading